Shaun Bagai - CEO of RenovoRX
Shaun Bagai, CEO of RenovoRX, shares his insights about leadership in biopharma and how RenovoRX is working to develop targeted oncology therapies and commercialize its FDA cleared drug delivery device.
Podcast Index
Explora podcasts por categoría, abre episodios recientes y descarga audio para escucharlo sin conexión.
BioBoss
John Simboli
Mendelspod Podcast
Theral Timpson
TED-Ed
TED-Ed
Paranormal UK Radio Network
Paranormal UK Radio Network
Τα podcasts του Newshub.gr
newshub.gr
Six Inches of Soil - The Podcast
Richard Tufton
Lightning Strikes Twice
Seattle Aquarium
Cultivating Place
Jennifer Jewell / Cultivating Place
Theory Underground
theory underground
ACEP Frontline
ACEP Frontline
Care More Be Better: A Podcast For Sustainable Social Impact and Regeneration
Corinna Bellizzi
The Med Device Cyber Podcast
Blue Goat Cyber
Pharmaceutical Executive
Pharmaceutical Executive Podcast
ERGO
ERGO PODCAST
CLACSO Radio
CLACSO
Grupos de trabajo de CLACSO - GT
CLACSO
Florida Uncut
Mason Gravley
My Weird Prompts
Daniel Rosehill
ШоПоКо
ШоПоКо
Strange and Unexplained
Cristina Gomez
Core Anesthesia
Tanner and Cole
New Matter: Inside the Minds of SLAS Scientists
SLAS
blckbx.tv
blckbx.tv
The Anti-Gravity Group Podcast
The Anti-Gravity Group - Braden Carlson, Taylor Jessee, Shane Harris, and Matthew Myers
The Athlete's Compass
Athletica
Rebel Economics with Professor Steve Keen
Professor Steve Keen
Southern Remedy
MPB Think Radio
Eye On The Sky
Vermont Public
Total Disclosure Podcast
Tyler Roberts
Precision Animal Training
Kirsten Kraljevic
Oncology Today with Dr Neil Love
Dr. Neil Love
Galactic Horrors
Galactic Horrors
PBS Space Time
PBS
Dogman Encounters Radio
Vic Cundiff
The Real Truth About Health Free 17 Day Live Online Conference Podcast
Lloyd Burrell, Keith Block M.D., Jeffrey Smith, Michael Klaper M.D., Ralph Moss, Brenda Davis R.D., Mark Sloan, Gerald Posner, Ian Harris M.D., Neil Barnard M.D., Will Tuttle Ph.D., John McDougall M.D., Pam Popper Ph.D., Gabriel Cousens M.D., Brian Clement Ph.D., Anna Maria Clement Ph.D., Marianne Williamson, Vandana Shiva Ph.D., Aly Cohen M.D., Milton Mills M.D., Theodora Scarato, William Li M.D., David Katz M.D., Stephanie Seneff Ph.D., Julieanna Hever M.S., Dale Bredesen M.D., Hope Bohanec, Kim Williams M.D., Joel Kahn M.D., Michelle Perro M.D., David Wolfe, Melanie Joy Ph.D., Sunil Pai M.D., Baxter Montgomery M.D., Michael Greger M.D., Caldwell Esselstyn M.D., Joel Fuhrman M.D., Colin Campbell Ph.D.
GL DEEP DIVES
Gorgorod
Ciencia
John Simboli
Shaun Bagai, CEO of RenovoRX, shares his insights about leadership in biopharma and how RenovoRX is working to develop targeted oncology therapies and commercialize its FDA cleared drug delivery device.
Hyung Heon Kim, CEO of MetaVia, shares his insights about leadership in biopharma and how MetaVia is working to transform cardiometabolic disease.
David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerabilit...
Stacy Lindborg, CEO of Imunon, shares her insights about leadership in biopharma and how Imunon is working to develop medicines that harness the building blocks of life to work in harmony with the body's immune system.
BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2026
Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fi...
Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.
Bruce Leuchter, CEO of Neurvati Neurosciences, shares his insights about leadership in biopharma and how Neurvati is working to advance drugs with the potential to improve the health and lives of people living with neuro...
Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.
Eduardo Bravo, CEO of Citryll, shares his insights about leadership in biopharma and how Citryll is working to transform the approach to treating immune mediated inflammatory diseases.
Abbas Kazimi, CEO of Nimbus Therapeutics, shares his insights about leadership in biopharma and how Nimbus is working to design and develop small molecule medicines capable of improving patients' lives.
Derek Adams, CEO of Stellular Bio, shares his insights about leadership in biopharma and how Stellular Bio is working to expand the reach of regenerative medicine.
Geoffrey Dow, CEO of 60 Degrees Pharmaceuticals, shares his insights about leadership in biopharma and how 60 Degrees Pharmaceuticals is working to develop vital medicines to treat and prevent infectious diseases.
Jorge Santos da Silva, co-founder and CEO of MoonLake Immunotherapeutics, shares his insights about leadership in biopharma and how MoonLake Immunotherapeutics is working to develop life changing therapies for people liv...
Vlad Vitoc, founder and CEO of MAIA Biotechnology, shares his insights with BioBoss host John Simboli about leadership in biopharma and how MAIA is working to develop and deliver innovative medicines to improve and exten...
“What leads a leader?”As you listen to clips from BioBoss podcasts, you may hear remarkably consistent ideas about leadership, as shared by BioBoss guests, who reflect on their younger years and how those experiences sha...
BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2025
Sam Clark, founder and CEO of Terran Biosciences, shares his insights with BioBoss host John Simboli about leadership in biopharma and how Terran is working to develop therapeutics and technologies for patients with neur...
Iain Kilty, CEO of Sitryx, shares his insights about leadership in biopharma and how Sitryx is working to alter immune cell metabolism to resolve disease
Steve Uden, co-founder and CEO of RallyBio, shares his insights about leadership in biopharma and how Rallybio is working to to profoundly change the odds for patients living with rare diseases.
Completa el formulario de abajo. Asegúrate de seleccionar tanto País como Géneros.
Envíanos un mensaje abajo. Te responderemos en un plazo de 24 horas.